Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid and Amiodarone for Postoperative AF Prophylaxis
NCT00953212Phase 3Completed
- Sponsor
- MaineHealth
- Start
- Aug 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ascorbic acid and amiodarone in Atrial fibrillation (AFib), sponsored by MaineHealth. Primary endpoint: Occurrence of Post-operative Atrial Fibrillation Requiring Treatment After Open Heart Surgery at 5 days. Started Aug 2009; status: completed.
02
Drugs
ascorbic acidamiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00953212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00953212.